These are separate programs, each has its own expertise.
Antibiotic Stewardship Certificate of Mastery (ASCOM™)
Antibiotic Stewardship Specialist Certification (AS-BC™)
NADONA is pleased to announce two exciting new programs: A new Antibiotic Stewardship Certificate of Mastery (ASCOM) and Antibiotic Stewardship Specialist Certification (AS-BC) programs.
The Certificate of Mastery Program registration was launched on February 1 and is open to all NADONA members and non-members. The new NADONA Certificate of Mastery will enable Post-Acute Care and Long-Term Care facilities to fully meet the new requirements from the Centers for Medicare and Medicaid Services for the knowledge domain on Antibiotic Stewardship. The entire program can be completed online, and must be completed within 90 days of program registration. Cost is $199 for non-members and $99 for members.
The content of the program also is aligned directly with the Core Elements of Antibiotic Stewardship for Nursing Homes released by the Centers for Disease Control and Prevention. Upon completion of the certificate program, a certificate of achievement will be earned enabling participants to sit for the professional certification and continuing education credits will be awarded for nurses. Completion of this exciting new program can also be counted as
continuing education towards the renewal of your NADONA Infection Prevention-Board Certification. Registration for the Certificate Program has begun on February 1 via the NADONA website.
The new professional certification will officially launch on March 1 and be open to nursing professionals as well as pharmacists and infection preventionists. To be eligible for the new board certification in antibiotic stewardship, the NADONA Antibiotic Stewardship Certificate of Mastery (ASCOM) must first be completed. Upon completion of the ASCOM program, healthcare professionals may earn the certification by successfully passing the certification examination. More details on the certification will be announced in the coming weeks.
For more information or for questions, contact Dr. Hudson Garrett via email: Hudson.email@example.com
• Identify the threats of antibiotic resistance in long term care settings
• Recognize the modes of organism transmission and acquired resistance
• Describe the evidence-based methods for building a comprehensive antibiotic stewardship program
Core Modules for the Certificate Program Include:
• Overview of Antibiotic Resistance
• Elements of Antibiotic Stewardship
• Leadership Commitment
• Drug Expertise
• Taking Action through Policy and Practice Change to Improve Antibiotic Use
• Tracking and Reporting Antibiotic Use and Outcomes
• Ongoing Education
• Didactic and Case Discussion
For more information email: Hudson.firstname.lastname@example.org
NADONA thanks Ocean Spray for their generous educational grant for the NADONA Antibiotic Stewardship Certificate of Mastery Program
Objectives of IP-BC™ Certification and Webinar Titles
DEVELOPING A ROAD-MAP FOR SUCCESS
Every healthcare worker has a responsibility to the patient
to provide them with safe care. Preventing infection through
competent and consistent practice is the expected, but current
rates of healthcare-associated infection demonstrate failures at
the individual and system levels.
The objective of this review is to outline foundational
care activities that represent best practice with respect to
prevention of infection, relating to care provided in the postacute
Sixteen current CDC guidelines were reviewed in order to
identify foundational infection prevention practices embedded
in those guidelines.
Eleven foundational practices were identified and are relevant
to care delivered in all healthcare settings. These included:
1) hand hygiene; 2) standard precautions; 3) personal
protective equipment; 4) transmission-based precautions; 5)
safe injection practices; 6) environmental hygiene; and 7)
personal health. In support of those practices, there must also
exist an emphasis on the following: 8) patient, family, and
caregiver education; 9) individual education and training; 10)
performance monitoring; and 11) support from leadership.
Healthcare personnel have a responsibility to reflect on their
current practice and determine where gaps exist in the ability
to perform these foundational practices. Using this knowledge,
individual performance improvement plans can be developed
that may provide their patients with care that reduces
Each of us, regardless of our roles in healthcare, has a
direct responsibility for the safety of those we serve. We
establish a promise, a covenant, with our patients that
we will provide them with our best care not just once, but
during every encounter. These three scenarios, or ones very
similar, are familiar to nearly every healthcare worker. Sadly,
they represent failure in both the systems of care as well as
individual performance of care.
Improving the use of antibiotics in healthcare to protect patients and reduce the threat of antibiotic resistance is a national priority. Antibiotic stewardship refers to a set of commitments and actions designed to “optimize the treatment of infections while reducing the adverse events associated with antibiotic use.”
The Centers for Disease Control and Prevention (CDC) recommends that all acute care hospitals implement an antibiotic stewardship program (ASP) and outlined the seven core elements which are necessary for implementing successful ASPs. CDC also recommends that all nursing homes take steps to improve antibiotic prescribing practices and reduce inappropriate use. Antibiotics are among the most frequently prescribed medications in nursing homes, with up to 70% of residents in a nursing home receiving one or more courses of systemic antibiotics when followed over a year.1
Similar to the findings in hospitals, studies have shown that 40–75% of antibiotics prescribed in nursing homes may be unnecessary or inappropriate. Harms from antibiotic overuse are significant for the frail and older adults receiving care in nursing homes. These harms include risk of serious diarrheal infections from Clostridium difficile, increased adverse drug events and drug interactions, and colonization and/or infection with antibiotic-resistant organisms.2,3 >>
Very Helpful Study Materials for IP-BC:
Members please log in before going to these links.